![CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4997-y/MediaObjects/12885_2018_4997_Fig1_HTML.png)
CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial | BMC Cancer | Full Text
![Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2012.605/MediaObjects/41416_2013_Article_BFbjc2012605_Fig1_HTML.jpg)
Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting | British Journal of Cancer
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![Table 1 from An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. | Semantic Scholar Table 1 from An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1de34a583d91d78e75729266b6207a43f586e45f/2-Table1-1.png)
Table 1 from An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. | Semantic Scholar
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr1.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/MyHome%20Article%20Library/821986/821986_Thumb_400.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis](https://www.frontiersin.org/files/Articles/821986/fonc-12-821986-HTML/image_m/fonc-12-821986-g001.jpg)
Frontiers | Elevated Carcinoembryonic Antigen at the Time of Recurrence as a Poor Prognostic Factor in Colorectal Cancer: A Propensity Score Matching Analysis
![A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80785-1/MediaObjects/41598_2020_80785_Fig1_HTML.png)
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
![Polymers | Free Full-Text | Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters Polymers | Free Full-Text | Purification of Colon Carcinoma Cells from Primary Colon Tumor Using a Filtration Method via Porous Polymeric Filters](https://pub.mdpi-res.com/polymers/polymers-13-03411/article_deploy/html/images/polymers-13-03411-ag.png?1633956169)